Back to Authors

Porquera, Eva M. Carmona

A5070267268 | I1330342723

Mayo Clinic

Citations 15

Anti-Inflammatory Therapy in Advanced Sarcoidosis: Results from The Registry for Advanced Sarcoidosis (REAS)

A38. GRANULOMATOUS LUNG DISEASE | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A1553-A1553

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1553

The Six-Minute Walk Test in Sarcoidosis Associated Pulmonary Hypertension: Results from an International Registry

A102. ILD DIAGNOSIS AND MONITORING | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A2574-A2574

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2574

Impact of Parenchymal Lung Disease in Echocardiographic Estimate of Pulmonary Artery Pressure in Sarcoidosis Patients

C52. USE YOUR ILLUSION II: CLINICAL RESEARCH IN PAH | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5081-A5081

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5081

Galectin-3 Plasma Levels and Secretion Mechanism in Idiopathic Pulmonary Fibrosis

C58. MECHANISMS OF PULMONARY FIBROSIS | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5233-A5233

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5233

Consistency of Automated Quantitation of Pulmonary Parenchymal Patterns on Normal, Low and Ultra-Low Dose CT

C22. ILD: DIAGNOSIS | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A4313-A4313

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4313